LearnGlossaryMarketStocksSuperinvestorsSign in

ARAY

Accuray Incorporated

Healthcare · $36M market cap

Verdict

We can't put a fair value on ARAY right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth0.6% a year✗
Equity per share growth-10.6% a year✗
Sales growth3.8% a year✗
Free cash flow growth7.3% a year✗
Return on invested capital-4.5%✗

Follow ARAY

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Jul 29, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

TCW GROUP INC

Owns 10%+ · 2026-07-29

J-Other

$6K

TCW GROUP INC

Owns 10%+ · 2026-07-29

J-Other

$80K

About Accuray Incorporated

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works